Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease-Reference-Cited by-同舟云学术

Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease

Published:2023-07-03 Issue:7 Volume:22 Page:563-579
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Richmond Angela M¹,Lyons Kelly E²,Pahwa Rajesh³

Affiliation:

1. Parkinson’s and Movement Disorders Division, Department of Neurology, The University of Kansas Medical Center, Kansas, KS, United States of America

2. Research and Education, Parkinson’s and Movement Disorders Division, Department of Neurology, The University of Kansas Medical Center, Kansas, KS, United States of America

3. Laverne & Joyce Rider Professor of Neurology, Chief, Parkinson’s and Movement Disorders Division Director, Parkinson’s Foundation Center of Excellence, The University of Kansas Medical Center, Kansas, KS, United States of America

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2227096

Reference171 articles.

1. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

2. Pathophysiology of motor fluctuations in Parkinson's disease

3. Levodopa Pharmacokinetics and Motor Performance During Activities of Daily Living in Patients With Parkinson's Disease on Individual Drug Combinations

4. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence;International Clinical Psychopharmacology;2024-08-21

2. A decision support system based on recurrent neural networks to predict medication dosage for patients with Parkinson's disease;Scientific Reports;2024-04-10

3. Compositional Features and Codon Usage Pattern of Genes Associated with Parkinson’s Disease;Molecular Neurobiology;2024-03-15

4. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson’s disease;Molecular Biology Reports;2024-02-24

5. Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability;Immunity & Ageing;2024-01-02